Food Intervention to Reduce Immunotherapy ToXicity

Abroad (travel likely)Recruiting

Conditions

Immune-related Adverse Event · Dietary Habits

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

UZ Brussel, Jette, Belgium
Contact: Study coordinator (Sandrine Aspeslagh, MD, PhD) · sandrine.aspeslagh@uzbrussel.be
Contact: Study coordinator (Marthe Verhaert, MD) · marthe.verhaert@uzbrussel.be · +3224779480

Study leads

Sandrine Aspeslagh, MD PhD
Principal Investigator
Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced Melanoma

Melanoma · Immune-related Adverse Event · Immune Checkpoint Inhibitor

Abroad (travel likely)RecruitingPHASE2

Guangzhou, China · Shenzhen, China

Inhaled Budesonide for REcurrence Prevention and Adjuvant THerapy in Checkpoint Inhibitor Pneumonitis

Pneumonitis · Immune-related Adverse Event

Abroad (travel likely)RecruitingPHASE2

Calgary, Canada

Immune-Related Adverse Events After Cancer Immunotherapy and Safety of Treatment Rechallenge

Immune-Related Adverse Events

Abroad (travel likely)Recruiting

Beijing, China

Early Adalimumab Induction for Immune Checkpoint Inhibitor Associated Inflammatory Arthritis

Inflammatory Arthritis · Immune-related Adverse Event

Abroad (travel likely)RecruitingPHASE2

London, Canada